Moreover, HIF-1α has been demonstrated to be an effective biomarker for predicting the outcomes of GC patients in a predictive model based on three ferroptosis‐related genes including HIF-1α, cation transport regulator homolog 1 (CHAC1) and NADPH oxidase 4 (NOX4) (10). This evidence concerns the gene HIF1A and gastric cancer.